The Effect of Pharmacist Counseling on Adherence to Antidiabetic Medications and Glycemic Control
Main Article Content
Abstract
Controlling blood glucose is paramount in diabetes management, yet medication non-adherence often hinders optimal outcomes. This study investigated the impact of pharmacist counseling on Fasting Blood Glucose (FBG) levels and medication adherence in Type 2 Diabetes Mellitus (T2DM) patients within a rural primary healthcare setting. A quasi-experimental pre- and post-test design was employed with 112 T2DM outpatients from Puskemas Simpang Mamplam, Bireuen City, Aceh, Indonesia, from March to April 2024. Medication adherence was assessed using the MARS-10 Questionnaire, and FBG levels were measured via finger prick. The majority of participants were female (79.5%), aged 41-60 (45.5%, mean age 55.70 ± 10.07 years), with secondary education (43.8%), predominantly sedentary/inactive workers (60.7%), and reported low-income (38.4%). Data analysis was performed using the Wilcoxon Signed rank Test. Following counseling, which was provided every two weeks over the two-months period, the mean medication adherence score significantly increased (p < 0.001) from 3.150 ± 0.942 to 8.790 ± 1.297. FBG levels also significantly decreased (p<0.05), from an initial mean of 308.98 ± 72.995 to 220.42 ± 68.547 at two weeks, 162.36 ± 50.191 at four weeks, and 130.00 ± 27.774 at six weeks. These findings suggest that pharmacist counseling significantly improves both medication adherence (p < 0.001) and glycemic control (FBG decrease, p < 0,05) in T2DM patients.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
[1]. Orabone AW, Do V, Cohen E. Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes. Diabetes, Metab Syndr Obes. 2022;15(June):1911–23.
[2]. Wahidin M, Achadi A, Besral B, Kosen S, Nadjib M, Nurwahyuni A, et al. Projection of diabetes morbidity and mortality till 2045 in Indonesia based on risk factors and NCD prevention and control programs. Sci Rep [Internet]. 2024;14(1):1–17. Available from: https://doi.org/10.1038/s41598-024-54563-2
[3]. Hening W, Sartika RD, Sauriasari R. Effect of hospital pharmacist counseling on clinical outcomes of type 2 diabetes mellitus outpatients. J Res Pharm Pract. 2019;8(3):155.
[4]. Wexler DJ. Patient education: Type 2 diabetes: Treatment (Beyond the Basics). May 20, 2024. 2024.
[5]. Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66(6):986–1002.
[6]. Selvadurai S, Makmor-Bakry M, Ali AM. An explorative qualitative study on pharmacist active engagement approach in primary healthcare diabetic education. Indones J Pharm. 2020;31(3):193–204.
[7]. WHO. Adherence to long-term therapies : evidence for action. World Health Organization; 2003.
[8]. Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Soc Adm Pharm [Internet]. 2019;15(9):1057–67. Available from: https://doi.org/10.1016/j.sapharm.2018.09.021
[9]. Pasadena Nursing Center. Differences In Health Services Between Urban And Rural Areas [Internet]. September 5. 2023. Available from: https://pasadenanursingcenter.com/differences-in-health-services-between-urban-and-rural-areas/#:~:text=Urban areas generally offer better,a higher concentration of healthcare
[10]. Elnaem MH, Nuffer W. Diabetes care and prevention services provided by pharmacists: Progress made during the COVID-19 pandemic and the need for additional efforts in the post-pandemic era. Explor Res Clin Soc Pharm [Internet]. 2022;6(November 2021):100137. Available from: https://doi.org/10.1016/j.rcsop.2022.100137
[11]. Nguyen TMH, Ngo TKC, Tran TTN, Le C. Evaluation of Factors Associated with Beliefs About Antidiabetic Medicine in Outpatients with Type 2 Diabetes in Vietnam. Indones J Pharm. 2023;34(4):675–85.
[12]. Terry DR, Peck B, Phan H, Hills D, Bishop J, Kirschbaum M, et al. Understanding rural pharmacists perspectives: lived experiences and insights associated with rural recruitment and retention. Rural Remote Health. 2024;24(1).
[13]. Indonesia Ministry of Health. Standard of Pharmaceutical Services in Community Health Centers (Minister of Health Regulation No. 74 of 2016) [Internet]. 74 2016. Available from: https://farmalkes.kemkes.go.id/unduh/permenkes-74-2016/#:~:text=Peraturan Menteri Kesehatan Nomor 74,Jenderal Kefarmasian dan Alat Kesehatan
[14]. PERKENI. Management and Prevention Guidelines for Type 2 Diabetes Mellitus in Indonesian Adults 2021 [Internet]. Jakarta: PB. PERKENI; 2021. 1–119 p. Available from: https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pengelolaan-dan-Pencegahan-DMT2-Ebook.pdf
[15]. Wibowo MINA, Fitri FM, Yasin NM, Kristina SA, Prabandari YS. Medication Adherence in Patients with Type 2 Diabetes in Several Health Centers of Banyumas District. J Kefarmasian Indones [Internet]. 2021;11(2):98–108. Available from: doi.org./10.22%0A435/jki.v11i2.3635%0D
[16]. Statistics Indonesia (BPS). Statistics of welfare 2018 [Internet]. Jakarta. 2019. Available from: https://www.bps.go.id/publication/2019/11/18/8885b57d077d70390a775191/statistik-kesejahteraan-rakyat-2018.html
[17]. Riches-Suman K. Increasing the Representation of Women in Diabetes Research. Diabetology. 2023;4(2):128–33.
[18]. Indrahadi D, Wardana A, Pierewan AC. The prevalence of diabetes mellitus and relationship with socioeconomic status in the Indonesian population. J Gizi Klin Indones. 2021;17(3):103.
[19]. Yogal C, Shakya S, Karmarcharya B, Koju R, Stunes AK, Mosti MP, et al. Diabetes Prevalence and Associated Risk Factors among Women in a Rural District of Nepal Using HbA1c as a Diagnostic Tool: A Population-Based Study. Int J Environ Res Public Health. 2022;19(12):1–15.
[20]. Bashir M, Fagier Y, Ahmed B, C Konje J. An overview of diabetes mellitus in pregnant women with obesity. Best Pract Res Clin Obstet Gynaecol [Internet]. 2024;93(December 2023):102469. Available from: https://doi.org/10.1016/j.bpobgyn.2024.102469
[21]. Tudurí E, Soriano S, Almagro L, Montanya E, Alonso-Magdalena P, Nadal Á, et al. The pancreatic β-cell in ageing: Implications in age-related diabetes. Ageing Res Rev. 2022;80(April).
[22]. Zhu M, Liu X, Liu W, Lu Y, Cheng J, Chen Y. β cell aging and age-related diabetes. Aging (Albany NY) [Internet]. 2021;13:7691–706. Available from: https://doi.org/10.18632/aging.202593
[23]. Kallio P, Pahkala K, Heinonen Oj, Tammelin T, Hirvensalo M, Telama R, et al. Physical Inactivity from Youth to Adulthood and Risk of Impaired Glucose Metabolism. Med Sci Sport Exerc [Internet]. 2018;50(6):1192–8. Available from: doi: 10.1249/MSS.0000000000001555
[24]. Lee MJ, Seo BJ, Kim YS. Impact of Education as a Social Determinant on the Risk of Type 2 Diabetes Mellitus in Korean Adults. Healthc. 2024;12(14):1–14.
[25]. CDC. National Diabetes Statistics Report [Internet]. may 15, 2024. 2024. Available from: https://www.cdc.gov/diabetes/php/data-research/index.html#print
[26]. Zissimopouloua O, Leontidoua E, Tsiptsiosb D, Manolisa A, Ioannidesc D, Trypsiania I, et al. Association of Family Income with Health Indices and Healthcare Utilization in a Large Sample of Residents in Northern Greece. MAEDICA – a J Clin Med. 2020;15(4):490–502.
[27]. Bird Y, Lemstra M, Rogers M, Moraros J. The relationship between socioeconomic status/income and prevalence of diabetes and associated conditions: A cross-sectional population-based study in Saskatchewan, Canada. Int J Equity Health [Internet]. 2015;14(1):1–8. Available from: https://dx.doi.org/10.1186/s12939-015-0237-0
[28]. Ministry of Health of the Republic of Indonesia (Kemenkes RI). Basic Health Research (RISKESDAS) 2018. Jakarta: Ministry of Health of the Republic of Indonesia (Kemenkes RI); 2018.
[29]. Masdin MR, Sartika RAD, Sauriasari R. Evaluation of pharmacist-led structured counselling on glycemic control and clinical outcomes of Type 2 diabetes mellitus patients at a health centre in East Jakarta, Indonesia. Pharm Educ. 2022;22(2):194–9.
[30]. Besemah NA, Sartika RAD, Sauriasari R. Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia. J Res Pharm Pract [Internet]. 2021;9(4):186–95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33912501%0Ahttps://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8067894
[31]. Rahmawaty A, Anggraeni NW. The Effect of Pharmacist Counseling on The Level Of Drug Compliance and Blood Sugar Levels in Diabetes Mellitus Patients. J Ris Kefarmasian Indones. 2023;5(1):181–93.
[32]. Fatiha CN, Sabiti FB. Improvement of Taking Medicines Compliance through Pharmacist Counseling in Type 2 Diabetes Mellitus Patients at Halmahera Public Health Center, Semarang City. J Pharm Sci Clin Res [Internet]. 2021;01:41–8. Available from: doi: 10.20961/jpscr.v6i1.39297
[33]. Goruntla N, Mallela V, Nayakanti D. Impact of Pharmacist-directed Counseling and Message Reminder Services on Medication Adherence and Clinical Outcomes in Type 2 Diabetes Mellitus. J Pharm Bioallied Sci. 2019;11(1):68–76.
[34]. Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life. Med. 2025;61(1):1–12.
[35]. Healthdirect. Diabetes testing and monitoring devices for blood sugar and ketone self-monitoring [Internet]. November 2022. 2022. Available from: https://www.healthdirect.gov.au/diabetes-testing-and-monitoring#:~:text=Blood glucose meter— a finger,needing to prick a finger
[36]. Rina H, Nasution A, Khairunisa. Impact of pharmacist counselingon the clinical outcomes in the management of type 2 diabetes mellitus outpatients admitted to a hospital. Int J Basic Clin Pharmacol. 2024;13(1):42–6.